Project Details
Description
This study is determining a tolerable dose of irinotecan in patients with ranging degrees of liver or renal dysfunction or prior pelvic radiation, and characterize the pharmacokinetics.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/99 → 9/30/02 |
Funding
- National Center for Research Resources